Huaren Pharmaceutical Co Ltd
Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therape… Read more
Huaren Pharmaceutical Co Ltd (300110) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.061x
Based on the latest financial reports, Huaren Pharmaceutical Co Ltd (300110) has a cash flow conversion efficiency ratio of 0.061x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥86.78 Million) by net assets (CN¥1.43 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Huaren Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Huaren Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Huaren Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huaren Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Happiest Minds Technologies Limited
NSE:HAPPSTMNDS
|
0.018x |
|
Sanlux Co Ltd
SHE:002224
|
-0.001x |
|
Lets Holding Group Co Ltd
SHE:002398
|
0.022x |
|
One Liberty Properties Inc
NYSE:OLP
|
0.015x |
|
Lingnan Landscape Co Ltd
SHE:002717
|
-0.002x |
|
PC1 Group JSC
VN:PC1
|
0.169x |
|
Mayora Indah Tbk
JK:MYOR
|
0.058x |
|
YLZ Information Tech Co
SHE:300096
|
-0.049x |
Annual Cash Flow Conversion Efficiency for Huaren Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Huaren Pharmaceutical Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.37 Billion | CN¥322.36 Million | 0.235x | +112.36% |
| 2023-12-31 | CN¥2.77 Billion | CN¥305.60 Million | 0.110x | +31.77% |
| 2022-12-31 | CN¥2.60 Billion | CN¥217.98 Million | 0.084x | +135.41% |
| 2021-12-31 | CN¥2.44 Billion | CN¥-578.52 Million | -0.237x | -5034.78% |
| 2020-12-31 | CN¥2.33 Billion | CN¥-10.74 Million | -0.005x | -103.35% |
| 2019-12-31 | CN¥2.25 Billion | CN¥309.33 Million | 0.138x | +21.89% |
| 2018-12-31 | CN¥2.25 Billion | CN¥254.32 Million | 0.113x | -17.22% |
| 2017-12-31 | CN¥1.55 Billion | CN¥211.08 Million | 0.136x | +14.53% |
| 2016-12-31 | CN¥1.53 Billion | CN¥181.65 Million | 0.119x | +813.41% |
| 2015-12-31 | CN¥1.44 Billion | CN¥18.77 Million | 0.013x | -70.59% |
| 2014-12-31 | CN¥1.48 Billion | CN¥65.56 Million | 0.044x | +62.55% |
| 2013-12-31 | CN¥1.46 Billion | CN¥39.78 Million | 0.027x | -63.29% |
| 2012-12-31 | CN¥1.34 Billion | CN¥99.44 Million | 0.074x | +48.64% |
| 2011-12-31 | CN¥1.19 Billion | CN¥59.53 Million | 0.050x | -28.93% |
| 2010-12-31 | CN¥1.10 Billion | CN¥77.61 Million | 0.070x | -42.90% |
| 2009-12-31 | CN¥313.80 Million | CN¥38.63 Million | 0.123x | -52.47% |
| 2008-12-31 | CN¥221.03 Million | CN¥57.24 Million | 0.259x | +524.40% |
| 2007-12-31 | CN¥184.68 Million | CN¥7.66 Million | 0.041x | -- |